Norepinephrine
Ended Purchase Order Awarded Last action
- Contract number
- W81K0022P0048
- Awardee
-
Wells Pharma Of Houston LLC UEI KZYSEB9YNPR4
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $408,899
Award facts
- Opportunity
-
- Naloxone and compounded pharmaceuticals Pre-Solicitation · W81K0022Q0012 · Posted Dec 6, 2021
- Contract value 64% obligated
- $639,602.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$268,010 | |
| Funding Only Action | $283,392 | |
| Funding Only Action | -$110,690 | |
| Funding Only Action | -$11 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$14 | |
| Funding Only Action | $261,992 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $242,239 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Show all 13
About this award
This is a $639,602.69 firm fixed-price purchase order awarded by the Defense Health Agency to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide critical pharmaceutical products including norepinephrine, ketamine, and naloxone solutions. The contract has a performance period through September 30, 2025.
This award is related to a previous sources sought notice issued by the Regional Health Contracting Office - Central on behalf of the San Antonio Military Medical Center, which sought to procure similar compounded pharmaceuticals to support medical treatment and healthcare operations. While that opportunity was initially set aside for small businesses, this contract was awarded on an unrestricted basis, indicating Wells Pharma's competitive positioning as a capable supplier of specialized pharmaceutical products to federal healthcare agencies. The company has previously held contracts with the Department of Veterans Affairs and the Defense Health Agency for 503B compounded pharmaceuticals and prefilled syringes.
Quick answers
Who was awarded contract W81K0022P0048?
W81K0022P0048 was awarded to Wells Pharma Of Houston LLC by Medical Command (Department of the Army) on January 21, 2022.
How much is contract W81K0022P0048 worth?
The government has obligated $408,899 on W81K0022P0048. Its current value, with exercised options, is $639,603.
Which agency awarded contract W81K0022P0048?
Medical Command (Department of the Army) awarded W81K0022P0048, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0022P0048 competed?
The extent of competition for W81K0022P0048 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award